UCSD License Agreement definition

UCSD License Agreement means that certain License Agreement by and between the Regents of the University of California (“UCSD”) and Prothena Ireland, effective as of November 4, 2013, as may be amended, which grants to Prothena Ireland and its Affiliates a license under UCSD’s interest in patent rights jointly owned with Prothena Ireland (the “UCSD/Prothena Patent Rights”).
UCSD License Agreement means that certain License Agreement, dated March 31, 2016, by and between Oncternal and The Regents of the University of California.
UCSD License Agreement means that certain License Agreement by and between the Regents of the University of California (“UCSD”) and Prothena Ireland, effective as of November 4, 2013, as may be amended, which grants to Prothena Ireland and its Affiliates a license under UCSD’s interest in patent rights jointly owned with Prothena Ireland (the “UCSD/Prothena Patent Rights”). 1.99.“Valid Claim” means, with respect to any country, a claim of (a) an unexpired issued Patent to the extent such claim has not been revoked or held invalid or unenforceable by a patent office, court or other governmental agency of competent jurisdiction in a final and non-appealable judgment (or judgment from which no appeal was taken within the allowable time period) and which claim has not been admitted to be invalid or unenforceable through reissue, reexamination, disclaimer, or otherwise in the relevant country, or (b) a Patent Application pending for less than [*] from its earliest priority date in the relevant country, provided that, for clarity, any claim of a Patent Application that is pending for more than [*] after its earliest priority date, as applicable, shall become a Valid Claim if it later issues and otherwise falls within subsection (a). 1.100.

Examples of UCSD License Agreement in a sentence

  • At any time prior to any amendment of the UCSD License Agreement, [*].

  • The Parties shall work in good faith to enter into the Sublicense Agreement on mutually acceptable terms within [*] following the amendment of the UCSD License Agreement.

  • In the event that any minimum annual royalty payment is triggered under Section 3.1(i) of the UCSD License Agreement from and after the first calendar year of commercial sales of Products by Assignee (or its Affiliates or sublicensees), a percentage of such minimum annual royalty payment shall be assigned to and assumed, paid and discharged by Assignee, which percentage shall represent the percentage of total earned royalties contributed by Oncternal (or its affiliates of sublicensees).

  • LICENSEE shall keep LICENSOR promptly informed of any development pertaining to the UCSD License Agreement that would reasonably be expected to have an adverse effect on LICENSOR’s rights under this Agreement or Oncternal’s rights under the UCSD License Agreement and in the event that such adverse effect could constitute a breach of the UCSD License Agreement that is uncured by LICENSEE, LICENSOR and/or Oncternal shall have the right to cure such breach.

  • All of the milestone payments payable under Section 3.1(c) of the UCSD License Agreement under subclause E thereof relating to Net Sales (as defined in the UCSD License Agreement) of Products shall be assigned to and assumed, paid and discharged by Assignee.

  • All of the milestone payments payable under Section 3.1(c) of the UCSD License Agreement under subclause B (“For the first ADC Licensed Product”) and subclause D (“For the first Antibody Fragment or Synthetic Antibody Licensed Product”) of such Section shall be assigned to and assumed, paid and discharged by Assignee.

  • Fifty percent (50%) of the annual license maintenance fee payable under Section 3.1(b) of the UCSD License Agreement from and after January 1, 2018 shall be assigned to and assumed, paid and discharged by Assignee.

  • Any and all Sublicense Fees or Sublicense royalty payments (as such terms are defined or used in the UCSD License Agreement) payable under Section 3.1(g)-(h) relating to any sublicense by or through Assignee related to the Products shall be assigned to and assumed, paid and discharged by Assignee.

  • Fifty percent (50%) of all payments due under Section 3.3(a)(ii) of the UCSD License Agreement shall be assigned to and assumed, paid and discharged by Assignee.

  • The royalty payments payable under Section 3.1(d) of the UCSD License Agreement relating to Net Sales (as defined in the UCSD License Agreement) of “ADC Licensed Products” and “Antibody Fragment or Synthetic Antibody Licensed Products” shall be assigned to and assumed, paid and discharged by Assignee.


More Definitions of UCSD License Agreement

UCSD License Agreement means that certain License Agreement by and between the Regents of the University of California (“ UCSD ”) and Prothena Ireland, effective as of November 4, 2013, as may be amended, which grants to Prothena Ireland and its Affiliates a license under UCSD’s interest in patent rights jointly owned with Prothena Ireland (the “ UCSD/Prothena Patent Rights ”).